3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Academic Disorder, Developmental in 2 studies
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Larkin, AE | 1 |
Fahey, B | 1 |
Gobbo, O | 1 |
Callaghan, CK | 1 |
Cahill, E | 1 |
O'Mara, SM | 1 |
Kelly, AM | 1 |
Patel, N | 1 |
Spangler, EL | 1 |
Greig, NH | 1 |
Yu, QS | 1 |
Ingram, DK | 1 |
Meyer, RC | 1 |
2 other studies available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Academic Disorder, Developmental
Article | Year |
---|---|
Blockade of NMDA receptors pre-training, but not post-training, impairs object displacement learning in the rat.
Topics: Analysis of Variance; Animals; Avoidance Learning; Behavior, Animal; Drug Administration Schedule; E | 2008 |
Phenserine, a novel acetylcholinesterase inhibitor, attenuates impaired learning of rats in a 14-unit T-maze induced by blockade of the N-methyl-D-aspartate receptor.
Topics: Animals; Cholinesterase Inhibitors; Excitatory Amino Acid Antagonists; Learning Disabilities; Male; | 1998 |